跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GAVISCON DOUBLE ACTION LIQUID, SUSPENSION - HSA Drug Approval Details
Approvals
/
HSA
/
GAVISCON DOUBLE ACTION LIQUID, SUSPENSION
Approved
STANDARD
GAVISCON DOUBLE ACTION LIQUID, SUSPENSION
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
4f5517db75be7e3d
Company
Unknown
Type
Standard
Approval Details
Approval Id
4f5517db75be7e3d
Drug Name
GAVISCON DOUBLE ACTION LIQUID, SUSPENSION
Active Ingredients
SODIUM BICARBONATE
213MG/10ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
4f5517db75be7e3d
Type
Standard
Back to HSA Approvals